Why we should close patent foramen ovale (PFO)

patent_foramen_ovale_bardeleben
Ralph Stephan von Bardeleben
2013-05-21

More articles by this author

How to prevent TAVI complications with current technology

Antonio Dager2013-05-21

TAVI: case complication

Marco Perin2013-05-21

Value of New Devices for Improving Outcomes

Eberhard Grube2013-05-21

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long-Term Predictors of Valve Deterioration After TAVI

Transcatheter aortic valve implantation (TAVI) has become an innovative technology for the treatment of patients with severe aortic valve stenosis. Initially implemented in elderly...

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study

The expansion of transcatheter aortic valve implantation (TAVI) toward younger and lower-risk patients has increased the relevance of post-procedural coronary access. In this context,...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...